Cipla completes $550 million acquisition of 2 US generic drug companies
Cipla has compled its $ 550-million (around Rs 3575 crore) acquisition of US generic drug makers InvaGen and Exelan. This ...
Tag: $550
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.